Close Menu

NEW YORK – Interpace Diagnostics said today that its subsidiary Interpace BioPharma has partnered with Beijing, China-based Genecast Biotechnology to jointly develop, promote, and offer translational studies and clinical trial solutions to biotech and pharmaceutical companies.  

As part of the collaboration, Parsippany, New Jersey-based Interpace will perform services worldwide except in China, where Genecast will provide services. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.